FDA Brief

Warning letters Drugs

FDA warning letter to

RPK Pharmaceuticals Inc.

Issued Mar 26, 2021Posted Apr 6, 2021Center for Drug Evaluation and Research

Failure to Comply with Drug Listing Requirements/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.